HDAC1 and cancer: However, inhibitors that disrupt MTA1 interactions with crucial binding partners, such as histone deacetylase 1 (HDAC-1) [26, 27], have been shown to reduce metastasis and MTA1 expression in cancer cell lines and animal models [28].